GlassScriptPhysician profile
Japhet G Joseph
NPI 1578531232
$3,995.14
in general payments reported to CMS, 2019-2025
28 companies · $11.05 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,733 · 2020: $1,058 · 2021: $563 · 2022: $377 · 2023: $116 · 2024: $138 · 2025: $11.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $264.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $683.17 | 2019-2025 | Lifevest |
| Abbott Laboratories | $648.38 | 2019-2024 | Optis, Xience Skypoint, Coroflow |
| Amgen INC. | $407.23 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $279.23 | 2019-2020 | |
| Astellas Pharma US INC | $261.51 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $257.18 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $254.97 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $173.21 | 2019-2020 | |
| Shockwave Medical, INC | $140.62 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $101.12 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $93.97 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $93.47 | 2019-2021 | |
| Cardiovascular Systems INC. | $92.10 | 2019-2022 | |
| Edwards Lifesciences Corporation | $77.98 | 2020 | |
| Lundbeck LLC | $63.26 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.46 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $58.15 | 2019 | |
| Amarin Pharma, INC. | $46.68 | 2019-2020 | |
| Abiomed | $33.10 | 2020-2021 | |
| Elutia, INC. | $33.07 | 2019 | |
| Novo Nordisk INC | $26.63 | 2019-2020 | |
| Zoll Circulation INC | $25.00 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $15.90 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $15.45 | 2021 | |
| Boston Scientific Corporation | $15.42 | 2019 | |
| Philips North America LLC | $14.49 | 2021 | |
| Esperion Therapeutics, INC. | $12.75 | 2020 | |
| Medtronic Vascular, INC. | $12.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Japhet Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.